CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.8029
-0.0371 (-4.42%)
At close: Aug 6, 2026, 4:00 PM EDT
0.8999
+0.0970 (12.08%)
Pre-market: Aug 7, 2026, 7:24 AM EDT
CytoMed Therapeutics Employees
CytoMed Therapeutics had 42 employees as of December 31, 2025. The number of employees decreased by 1 or -2.33% compared to the previous year.
Employees
42
Change (1Y)
-1
Growth (1Y)
-2.33%
Revenue / Employee
$15,935
Profits / Employee
-$73,683
Market Cap
9.50M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 42 | -1 | -2.33% |
| Dec 31, 2024 | 43 | 9 | 26.47% |
| Dec 31, 2023 | 34 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Curis | 24 |
| Lisata Therapeutics | 21 |
| BioCardia | 21 |
| IN8bio | 18 |
| Theriva Biologics | 16 |
| BioVie | 13 |
| Lexaria Bioscience | 7 |
| Quoin Pharmaceuticals | 6 |
GDTC News
- 4 months ago - CytoMed Therapeutics Annual report: H2 2025 - Filings
- 6 months ago - Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress - TheFly
- 7 months ago - Cytomed sees ‘enough resources’ to continue activites for ‘at least a year’ - TheFly
- 8 months ago - Cytomed Therapeutics enters into MoU with UMMC - TheFly
- 9 months ago - CytoMed completes acquisition of T cell technology of TC BioPharm - TheFly
- 9 months ago - Cytomed Therapeutics secures investment for subsidiary LongevityBank - TheFly
- 10 months ago - Cytomed Therapeutics chairman Peter Choo increases holdings to 21.95% - TheFly
- 10 months ago - Cytomed announces cash bid for potential acquisition of TC BioPharm - TheFly